4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity

MLA

Darko Kocjan, et al. “4-Substituted Trinems as Broad Spectrum Beta-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity.” Journal of Medicinal Chemistry, vol. 50, no. 17, Aug. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0558f49387f0a2db24d2c10cda9b7dcb&authtype=sso&custid=ns315887.

APA

Darko Kocjan, Miha Andrejašič, Tom Solmajer, Tomaz Mesar, Andrej Kocijan, Petra Stefanic Anderluh, Dušan Turk, Mateja Vilar, Lovro Selic, Tadeja Prevec, Anton Copar, Andrej Prezelj, Gregor Vilfan, Uroš Urleb, Marko Oblak, Lars Hesse, & Ivan Plantan. (2007). 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity. Journal of Medicinal Chemistry, 50(17).

Chicago

Darko Kocjan, Miha Andrejašič, Tom Solmajer, Tomaz Mesar, Andrej Kocijan, Petra Stefanic Anderluh, Dušan Turk, et al. 2007. “4-Substituted Trinems as Broad Spectrum Beta-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity.” Journal of Medicinal Chemistry 50 (17). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0558f49387f0a2db24d2c10cda9b7dcb&authtype=sso&custid=ns315887.